Private Equity

Updated:

Green Park & Golf Ventures

Carl Westcott's Dallas venture firm concentrates on early-stage digital health and healthcare IT, deploying family capital from his 1-800-Flowers exit.

Green Park & Golf Ventures logo

Green Park & Golf Ventures

Green Park & Golf Ventures was founded in Dallas, Texas by serial entrepreneur Carl Westcott and Dr. Clay Heighten, an emergency medicine physician. The firm deploys capital generated from Westcott's 2007 sale of his company, the 1-800-Flowers.com subsidiary, to a private equity consortium. GPGV formalizes what began as Westcott's personal angel investing activity, structuring a venture firm that blends operator experience with clinical domain knowledge. The firm invests primarily across early-stage, seed, and growth equity rounds, with a heavy emphasis on digital health and healthcare services. GPGV's portfolio companies target infrastructure problems in the U.S. healthcare system — clinical workflow automation, remote patient monitoring, and AI-enabled diagnostics. Confirmed positions include TelaDoc Health, where Westcott was an early backer prior to its 2015 IPO, and other early-stage digital health companies concentrated in Texas and California (per the firm's official communications). The partnership evaluates direct investments and co-investments alongside other venture firms, typically leading or co-leading seed and Series A rounds. GPGV operates from its headquarters in Dallas, with investment activity radiating into both coastal and Sunbelt startup ecosystems. The Westcott family's broader investment architecture includes Westcott LLC, a holding company that manages diverse operating businesses and real estate assets. Team composition and deployment figures remain undisclosed. Carl Westcott, now in his 80s, maintains an active role in the firm's investment decisions, while day-to-day deal execution is handled by the partnership. The firm's structural distinction lies in its dual-operator DNA: one founder's clinical background as a practicing emergency physician gives GPGV an edge in diligence for early-stage health-tech deals, while the other's history as a serial entrepreneur allows the firm to underwrite with an operator's eye. This combination — a clinician and a veteran founder deploying family wealth — yields a sourcing and evaluation posture that differs from both standard institutional venture capital and passive family-office direct investing.

General information

Firm type

Private Equity

Year founded

AUM

Undisclosed

Location

Region

North America

Country

United States

City

Dallas

Corporate office

Dallas, TX, United States

Sector focus

Digital HealthEnterprise SoftwareAI/MLHealthcare Services

Frequently asked questions

Who runs investment decisions at Green Park & Golf Ventures?

Investment decisions are primarily managed by founders Carl Westcott and Dr. Clay Heighten. Westcott brings the capital and serial-operator experience, including building and selling a 1-800-Flowers.com subsidiary. Heighten, a practicing emergency medicine physician, contributes clinical domain expertise that shapes the firm's healthcare-focused deal evaluation.

Is Green Park & Golf Ventures a single family office or a venture firm?

Green Park & Golf Ventures operates as a hybrid. It deploys Carl Westcott's family wealth but functions with the structure and discipline of an early-stage venture firm — leading rounds, taking board seats, and co-investing alongside other venture investors. The firm externalizes its investment activity rather than operating as a private family office managing only internal capital.

Which sectors does Green Park & Golf Ventures focus on?

The firm concentrates on digital health, healthcare IT, and tech-enabled healthcare services. Portfolio interests include clinical workflow software, remote patient monitoring, AI-enabled diagnostics, and enterprise tools for hospital systems and payers. GPGV generally avoids therapeutics, medical devices, and biotech.

What investment stages does Green Park & Golf Ventures typically target?

GPGV predominantly invests at seed and Series A stages, selectively following on through growth rounds. The firm's sweet spot is early-stage companies with working prototypes or early commercial traction that address structural inefficiencies in the U.S. healthcare system.

Where does the underlying wealth for Green Park & Golf Ventures come from?

The wealth originates from Carl Westcott's sale of his company, the 1-800-Flowers.com subsidiary, to a private equity consortium in 2007. Westcott had earlier entrepreneurial exits in the telecommunications sector dating to the 1980s and 1990s.

How does Green Park & Golf Ventures source its deals?

Sourcing relies heavily on the founders' networks — Westcott's decades-long ties to Texas entrepreneurs and Heighten's connections within the clinical and healthcare-administration communities. The firm also sources through co-investor relationships and the Dallas-area startup ecosystem.

Does Green Park & Golf Ventures participate in fund commitments or only direct deals?

GPGV executes direct investments rather than making fund commitments. The partnership writes checks directly into companies, though it may co-invest alongside other venture capital firms on the same terms. There is no publicly reported fund structure.

Profile maintained by using OSINT (open-source intelligence), regulatory filings, licensed data partners, and verified direct submissions. Read the methodology. Last updated: . Continuous refresh with full update cycles at least every 30 days.

Need institutional-grade insight on private equity firms?

Altss delivers:

Principals with verified direct contactsAllocation history by asset classOSINT-derived deal signals
Book a demo

Prefer a guided tour?

We’ll walk you through:

Interactive funding timelinesCustom mandate & allocation filters
Book a demo

Browse by category

More Dallas Private Equity profiles